Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.
about
The voltage gated Ca(2+)-channel Cav3.2 and therapeutic responses in breast cancerAloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cellsNucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).A critical look at the function of the P2Y11 receptor.Molecular mechanisms of tumour invasion: regulation by calcium signals.Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling.Purinergic Signalling: Therapeutic Developments.TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells.Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells.Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signalHypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells.P2Y11 Receptors: Properties, Distribution and Functions.Endothelial Ca2+ Signaling and the Resistance to Anticancer Treatments: Partners in Crime.Regulation of matrix stiffness on the epithelial-mesenchymal transition of breast cancer cells under hypoxia environment.Assessment of CXC ligand 12-mediated calcium signalling and its regulators in basal-like breast cancer cells.Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis.Real-time scratch assay reveals mechanisms of early calcium signaling in breast cancer cells in response to wounding.
P2860
Q36749041-52E89C15-DD4C-4885-B766-1B643E87F617Q37644791-3F3F9584-C861-429D-BD07-8CE837FAA63CQ37677827-56F3A16C-F634-42CC-9CE5-B1638A95BD49Q38849452-0221E071-EB2D-48BF-92E5-5E3B96BA7E2CQ39183513-FB2AAEFB-72BD-4215-88B5-DB11C9AB3A92Q41003127-50955898-E77C-4ADF-9B94-431B846F4867Q42367885-F996CE55-6CFC-4A00-91DA-B950BF476F53Q42510422-9EBEAEE4-09C2-4AA6-A9DD-A23472224151Q42513050-21E2D2C8-9564-4783-B5D1-0AAC3D14592DQ42700801-0B3B643A-3DE3-4916-A554-BE9ABDFE8155Q46264415-EBF46753-0819-4750-9FE7-BCB11B797CCBQ47406063-39E7A937-77AE-4404-B1AA-8EEFA0F43D29Q48260240-A03125DA-7F44-4DEB-A882-E2B9E79D6DAAQ48314608-6FA916CD-ECD5-4A1B-A8CB-77BC76618D27Q52655168-3187865B-BA44-4043-8A10-DA2501F7C205Q52673010-305EB9BA-310A-48F0-A7E8-2D9E839C5402Q54943752-947C4EC5-1D4B-4A16-A744-DB8F202227D4
P2860
Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Altered purinergic receptor-Ca ...... sition in breast cancer cells.
@en
type
label
Altered purinergic receptor-Ca ...... sition in breast cancer cells.
@en
prefLabel
Altered purinergic receptor-Ca ...... sition in breast cancer cells.
@en
P2093
P2860
P50
P1433
P1476
Altered purinergic receptor-Ca ...... sition in breast cancer cells.
@en
P2093
Daneth L Marcial
Hannah Beilby
Paraic A Kenny
P2860
P304
P356
10.1016/J.MOLONC.2015.09.006
P577
2015-09-25T00:00:00Z